Macroaxis: Personalized Investing

Personalized Investing and

Digital Wealth Optimization

GILD    AMGN    CELG    BIIB    
Benchmark  United States  NYSE  11,014   9.582 Index Moved Up 0.09%  

Collecting data for MSTX

Mast price prediction Mast price prediction

Investment horizon:  
  30 Days    Login   to change
With this exotic module your can estimate the sentimental value of Mast Therapeutics Inc from the prospective of Mast response to recently generated media hype and the effects of current headlines on its competitors. The module also provides analysis of price elasticity to changes in media outlook on Mast over a specific investment horizon. See also Mast Backtesting, Mast Volatility, Mast Valuation, Mast Correlation, Mast History and Mast Performance

Mast hype analysis

Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
Price Moved Up 1.00% 4.01%Price Moved Up 0.03% Price Moved Up 0.39% 1 Events / Month2 Events / MonthUncertain
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.550.585.22% Mast price prediction up

Mast estimiated after-hype price volatility

Next price density
Expected price to next headline
March 6, 2015
Current Value
Downside upside
After-hype Price
Upside upside
Mast is abnormally risky asset. Analysis and calculation of next after-hype price of Mast Therapeutics is based on 1 month time horizon.

Mast hype timeline

Mast Therapeutics Inc is now traded for 0.55 . This company has historical hype elasticity of 0.03 and average elasticity to hype of competition of 0.39. Mast Therapeutics Inc is projected to increase in value after the next headline with price going to jump to 0.58. The average volatility of media hype impact on the company stock price is about 13366.67%. The price appreciation on the next news is estimated to be 5.22% where as daily expected return is now at 1.0%. The volatility of related hype on Mast is about 1038.86% with expected price after next announcement by competition of 0.94. Mast Therapeutics currently holds about 43.07 M in cash with (23.49 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.34. Given the investment horizon of 30 days, the next projected press release will be uncertain.
See also Mast Backtesting, Mast Volatility, Mast Valuation, Mast Correlation, Mast History and Mast Performance
Mast Value 
Benchmark  Embed   Timeline 

Mast related hype analysis

Short fall
At Risk
Gilead Sciences Inc 0.50 2 per month 0.00 (0.06) 0.00  1.85 (1.16) 10.89 
Amgen Inc 1.56 2 per month 0.00  0.16  0.00  1.21 (0.79) 2.49 
Celgene Corporation 0.56 2 per month 0.00 (0.03) 0.00  1.80 (1.53) 4.21 
Biogen Idec Inc(2.21)1 per month 0.00  0.34  0.00  1.60 (0.90) 2.50 
Regeneron Pharmaceuticals Inc 1.32 2 per month 0.00  0.03  0.00  3.85 (1.44) 6.56 
Alexion Pharmaceuticals Inc(2.54)3 per month 0.00 (0.01) 0.00  2.90 (2.77) 5.24 
Illumina Inc 1.50 2 per month 0.00  0.02  0.00  1.87 (1.71) 3.62 
Vertex Pharmaceuticals Incorporated 0.09 2 per month 0.00  0.26  0.00  5.76 (2.21) 8.74 
BioMarin Pharmaceutical Inc 0.71 2 per month 0.00  0.39  0.00  3.11 (1.87) 4.78 
Incyte Corporation 2.37 1 per month 0.00  0.26  0.00  4.62 (2.69) 7.45 


Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder

Research Modules

Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management

Services And Technology

Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing

Free Investor Tools

World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis

About Us

About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities